Pharmacokinetic and Pharmacodynamic Properties of Calaspargase Pegol Escherichia coli L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Study AALL07P4

PURPOSE: Asparaginase is a critical agent used to treat acute lymphoblastic leukemia (ALL). Pegaspargase (SS-PEG), a pegylated form of Escherichia coli L-asparaginase with a succinimidyl succinate (SS) linker, is the first-line asparaginase product used in Children's Oncology Group (COG) ALL tr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Oncol
Main Authors: Angiolillo, Anne L., Schore, Reuven J., Devidas, Meenakshi, Borowitz, Michael J., Carroll, Andrew J., Gastier-Foster, Julie M., Heerema, Nyla A., Keilani, Taha, Lane, Ashley R., Loh, Mignon L., Reaman, Gregory H., Adamson, Peter C., Wood, Brent, Wood, Charlotte, Zheng, Hao W., Raetz, Elizabeth A., Winick, Naomi J., Carroll, William L., Hunger, Stephen P.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2014
Teme:
ORIGINAL REPORTS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4239306/
https://ncbi.nlm.nih.gov/pubmed/25348002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.5763
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki